Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Natalia M. Flores, Javier Nuevo, Alyssa B. Klein, Scott Baumgartner & Robert Morlock. (2019) The economic burden of uncontrolled gout: how controlling gout reduces cost. Journal of Medical Economics 22:1, pages 1-6.
Read now
Read now
Rita N Cunha, Renata Aguiar & Filipa Farinha. (2018) Impact of pegloticase on patient outcomes in refractory gout: current perspectives. Open Access Rheumatology: Research and Reviews 10, pages 141-149.
Read now
Read now
Aki Shiozawa, Erin K. Buysman & Stephanie Korrer. (2017) Serum uric acid levels and the risk of flares among gout patients in a US managed care setting. Current Medical Research and Opinion 33:1, pages 117-124.
Read now
Read now
Gary Ruoff & N. Lawrence Edwards. (2016) Overview of Serum Uric Acid Treatment Targets in Gout: Why Less Than 6 mg/dL?. Postgraduate Medicine 128:7, pages 706-715.
Read now
Read now
Sandra Pamela Chinchilla, Irati Urionaguena & Fernando Perez-Ruiz. (2016) Febuxostat for the chronic management of hyperuricemia in patients with gout. Expert Review of Clinical Pharmacology 9:5, pages 665-673.
Read now
Read now
Articles from other publishers (58)
Yan Wang, Xiaoxi Zhang, Changyu Xu, Yanjing Yao, Chenxi Wu, Wenjing Xu, Fenfen Li & Daozong Xia. (2023) Neoisoastilbin Ameliorates Acute Gouty Arthritis via Suppression of the NF-κB/NLRP3 Pathway. Evidence-Based Complementary and Alternative Medicine 2023, pages 1-8.
Crossref
Crossref
Fatemeh Amiri, Ali-Asghar Kolahi, Seyed Aria Nejadghaderi, Maryam Noori, Alireza Khabbazi, Mark J.M. Sullman, Jay S. Kaufman, Gary S. Collins & Saeid Safiri. (2023) The Burden of Gout and Its Attributable Risk Factors in the Middle East and North Africa Region, 1990 to 2019. The Journal of Rheumatology 50:1, pages 107-116.
Crossref
Crossref
Till Uhlig, Lars F. Karoliussen, Joe Sexton, Tore K. Kvien, Espen A. Haavardsholm, Fernando Perez-Ruiz & Hilde Berner Hammer. (2022) One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study. Arthritis Research & Therapy 24:1.
Crossref
Crossref
Gill Verstappen, Olaf Michel, Stijn Halewyck, Vedat Topsakal & Antje Pössneck. (2022) Infected nasal gout tophus: A case report. Clinical Case Reports 10:12.
Crossref
Crossref
Ruth Topless, Siamak Noorbaloochi, Tony R Merriman & Jasvinder A. Singh. (2022) Change in serum urate level with urate-lowering therapy initiation associates in the immediate term with patient-reported outcomes in people with gout. Seminars in Arthritis and Rheumatism 56, pages 152057.
Crossref
Crossref
Ritch te Kampe, Tim L. Jansen, Caroline van Durme, Matthijs Janssen, Gudula Petersen & Annelies Boonen. (2022) Outcomes of Care Among Patients With Gout in Europe: A Cross-sectional Survey. The Journal of Rheumatology 49:3, pages 312-319.
Crossref
Crossref
Gehan Hamdalla, Noor Ali AlGhanem, Hatem Abdulaziz Mohammed AlGhamdi, Bashayer Fahad AlHazmi, Majed Rashed AlHarthi, Mohammed Nawar AlOtaibi, Amnah Ali Elagi, Abobakr Ali AlQarni, Jumanah Ali AlZahrani, Abeer Fahad AlMutairi & Saleh Abdullah Mohammed. (2022) Review on Diagnosis & Management of Gout in Primary Health Care. Pharmacophore 13:2, pages 121-124.
Crossref
Crossref
Christina Derksen, Rachel Murdoch, Keith J. Petrie & Nicola Dalbeth. (2021) “An apple pie a day does not keep the doctor away”: Fictional depictions of gout in contemporary film and television. BMC Rheumatology 5:1.
Crossref
Crossref
Meykkumar Meyappan, Wei Siong Aaron Loh, Li Yen Tan, Sheng Feng Ian Tan, Pey Ying Ho, Yih Jia Poh & Ngiap Chuan Tan. (2021) Development of a novel gout treatment patient decision aid by patient and physician: A qualitative research study. Health Expectations 24:2, pages 431-443.
Crossref
Crossref
Saeid Safiri, Ali‐Asghar Kolahi, Marita Cross, Kristin Carson‐Chahhoud, Damian Hoy, Amir Almasi‐Hashiani, Mahdi Sepidarkish, Ahad Ashrafi‐Asgarabad, Maziar Moradi‐Lakeh, Mohammad Ali Mansournia, Jay S. Kaufman, Gary Collins, Anthony D. Woolf, Lyn March & Emma Smith. (2020) Prevalence, Incidence, and Years Lived With Disability Due to Gout and Its Attributable Risk Factors for 195 Countries and Territories 1990–2017: A Systematic Analysis of the Global Burden of Disease Study 2017. Arthritis & Rheumatology 72:11, pages 1916-1927.
Crossref
Crossref
Vitalii Evgenovich Kondratiuk, Oksana Mykhailivna Tarasenko, Olena Myroslavivna Karmazina & Valentyn Valentinovich Taranchuk. (2020) Impact of the Synbiotics and Urate-Lowering Therapy on Gut Microbiota and Cytokine Profile in Patients with Chronic Gouty Arthritis. Journal of Medicine and Life 13:4, pages 490-498.
Crossref
Crossref
U. O. Mudra. (2020) GOUT AND NONALCOHOLIC FATTY LIVER DISEASE: EFFECT OF ENTEROSORPTION’S ADDITION TO COMMON TREATMENT. International Journal of Medicine and Medical Research 5:2, pages 40-46.
Crossref
Crossref
Tokunbo Falohun & Michael J. McShane. (2020) An Optical Urate Biosensor Based on Urate Oxidase and Long-Lifetime Metalloporphyrins. Sensors 20:4, pages 959.
Crossref
Crossref
Li Ling Seow, Nana Jiao, Wenru Wang, Eleanor Holroyd, Gim Gee Teng & Hong-Gu He. (2018) A Qualitative Study Exploring Perceptions of Patients With Gout. Clinical Nursing Research 29:1, pages 56-65.
Crossref
Crossref
Carly A. Janssen, Martijn A. H. Oude Voshaar, Peter M. ten Klooster, Tim L. Th. A. Jansen, Harald E. Vonkeman & Mart A. F. J. van de Laar. (2019) A systematic literature review of patient-reported outcome measures used in gout: an evaluation of their content and measurement properties. Health and Quality of Life Outcomes 17:1.
Crossref
Crossref
Charleen Yeo, Sanghvi Kaushal, Beatrice Lim, Nicholas Syn, Aung Myint Oo, Jaideepraj Rao, Aaryan Koura & Danson Yeo. (2019) Impact of bariatric surgery on serum uric acid levels and the incidence of gout—A meta‐analysis. Obesity Reviews 20:12, pages 1759-1770.
Crossref
Crossref
C. A. Janssen, M. A. H. Oude Voshaar, P. M. ten Klooster, H. E. Vonkeman & M. A. F. J. van de Laar. (2019) Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare. Clinical Rheumatology 38:8, pages 2233-2239.
Crossref
Crossref
Wenting Fan, Jiaan Zhu, Zheng Chen & Wenxue Li. (2019) Ultrasound Features of the First Gout Attack and the Association with Duration of Hyperuricemia. Iranian Journal of Radiology 16:3.
Crossref
Crossref
Zachary Bowen‐Davies, Sara Muller, Christian D. Mallen, Richard A. Hayward & Edward Roddy. (2018) Gout Severity, Socioeconomic Status, and Work Absence: A Cross‐Sectional Study in Primary Care. Arthritis Care & Research 70:12, pages 1822-1828.
Crossref
Crossref
Asnat Raziel. (2018) Gout, obesity and bariatric surgery. Advances in Obesity, Weight Management & Control 8:4.
Crossref
Crossref
Fan Hong, Pengfei Xu & Yonggong Zhai. (2018) The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development. International Journal of Molecular Sciences 19:8, pages 2189.
Crossref
Crossref
M. Gamala, S. P. Linn-Rasker, M. Nix, B. G. F. Heggelman, J. M. van Laar, P. C. M. Pasker-de Jong, J. W. G. Jacobs & R. Klaasen. (2018) Gouty arthritis: decision-making following dual-energy CT scan in clinical practice, a retrospective analysis. Clinical Rheumatology 37:7, pages 1879-1884.
Crossref
Crossref
Luigi Schiavo, Guillaume Favrè, Vincenzo Pilone, Gianluca Rossetti, Gabriele De Sena, Antonio Iannelli & Alfonso Barbarisi. (2017) Low-Purine Diet Is More Effective Than Normal-Purine Diet in Reducing the Risk of Gouty Attacks After Sleeve Gastrectomy in Patients Suffering of Gout Before Surgery: a Retrospective Study. Obesity Surgery 28:5, pages 1263-1270.
Crossref
Crossref
Valgerdur Sigurdardottir, Panagiota Drivelegka, Anna Svärd, Lennart T H Jacobsson & Mats Dehlin. (2018) Work disability in gout: a population-based case–control study. Annals of the Rheumatic Diseases 77:3, pages 399-404.
Crossref
Crossref
Angelo L. Gaffo, Nicola Dalbeth, Kenneth G. Saag, Jasvinder A. Singh, Elizabeth J. Rahn, Amy S. Mudano, Yi-Hsing Chen, Ching-Tsai Lin, Sandra Bourke, Worawit Louthrenoo, Janitzia Vazquez-Mellado, Hansel Hernández-Llinas, Tuhina Neogi, Ana Beatriz Vargas-Santos, Geraldo da Rocha Castelar-Pinheiro, Rodrigo B. C. Amorim, Till Uhlig, Hilde B. Hammer, Maxim Eliseev, Fernando Perez-Ruiz, Lorenzo Cavagna, Geraldine M. McCarthy, Lisa K. Stamp, Martijn Gerritsen, Viktoria Fana, Francisca Sivera & William Taylor. (2018) Brief Report: Validation of a Definition of Flare in Patients With Established Gout. Arthritis & Rheumatology 70:3, pages 462-467.
Crossref
Crossref
Leslie R. Harrold, Carol J. Etzel, Allan Gibofsky, Joel M. Kremer, Michael H. Pillinger, Kenneth G. Saag, Naomi Schlesinger, Robert Terkeltaub, Vanessa Cox & Jeffrey D. Greenberg. (2017) Sex differences in gout characteristics: tailoring care for women and men. BMC Musculoskeletal Disorders 18:1.
Crossref
Crossref
Allison Guttmann, Svetlana Krasnokutsky, Michael H. Pillinger & Adey Berhanu. (2017) Pegloticase in gout treatment - safety issues, latest evidence and clinical considerations. Therapeutic Advances in Drug Safety 8:12, pages 379-388.
Crossref
Crossref
Robert T. Keenan. (2017) Limitations of the Current Standards of Care for Treating Gout and Crystal Deposition in the Primary Care Setting: A Review. Clinical Therapeutics 39:2, pages 430-441.
Crossref
Crossref
Eugene Y. Kissin & Michael H. Pillinger. (2017) Editorial: The Sound and the Fury: Musculoskeletal Ultrasound in the Diagnosis of Gout. Arthritis & Rheumatology 69:2, pages 249-252.
Crossref
Crossref
Jeffrey Poiley, Alexandra S. Steinberg, Yun‐Jung Choi, Charles S. Davis, Robert L. Martin, Charles A. McWherter, Pol F. Boudes, H. Bays, D. Bolshoun, E. Bolster, D. Cheung, C. Cone, R. DeGarmo, J. Earl, I. El Asmar, D. Felber, D. Fitz‐Patrick, A. Gaffo, G. Gottschlich, J. Greenwald, C. Griffin, M. Guice, W. Harper, J. Hill, C. Huffman, R. HulingJr.Jr., F. Johnson, S. Kafka, J. Keane, W. Kirby, J. Kirstein, E. Kolettis, G. Lefebvre, A. Mabaquiao, K. Maynard, H. McIlwain, R. McNeill, D. Mehta, R. Montgomery, C. Morgan, J. Poiley, S. Powell, K. Radbill, M. Reschak, R. Surowitz, J. Tarro, M. Turner, F. Velazquez, L. Watkins, J. White, H. Williams, J. Wilson, F. Zaidi, S. Henein, A. Toma, T. Burtchuladze, E. Kartvelishvili, L. Kilasonia, L. Lagvilava, L. Shalamberidze & N. Tsiskarishvili. (2016) A Randomized, Double‐Blind, Active‐ and Placebo‐Controlled Efficacy and Safety Study of Arhalofenate for Reducing Flare in Patients With Gout. Arthritis & Rheumatology 68:8, pages 2027-2034.
Crossref
Crossref
Hari Madhuri Doss, Chandrima Dey, C. Sudandiradoss & Mahaboob Khan Rasool. (2016) Targeting inflammatory mediators with ferulic acid, a dietary polyphenol, for the suppression of monosodium urate crystal-induced inflammation in rats. Life Sciences 148, pages 201-210.
Crossref
Crossref
Thomas Bardin, St?phane Bou?e, Pierre Clerson, G?rard Chal?s, Ren?-Marc Flipo, Fr?d?ric Liot?, Vincent Perez, Thierry Poiraud, Thierry Schaeverbeke & Pascal Richette. (2016) Prevalence of Gout in the Adult Population of France. Arthritis Care & Research 68:2, pages 261-266.
Crossref
Crossref
Jasvinder Singh & Nipam Shah. 2016. Patient Reported Outcome Measures in Rheumatic Diseases. Patient Reported Outcome Measures in Rheumatic Diseases
225
247
.
Bridget Teevan Burke, Anna K?ttgen, Andrew Law, Beverly Gwen Windham, Dorry Segev, Alan N. Baer, Josef Coresh & Mara A. McAdams-DeMarco. (2015) Physical Function, Hyperuricemia, and Gout in Older Adults. Arthritis Care & Research 67:12, pages 1730-1738.
Crossref
Crossref
Nazia Rashid, Gerald D. Levy, Yi-Lin Wu, Chengyi Zheng, River Koblick & T. Craig Cheetham. (2015) Patient and clinical characteristics associated with gout flares in an integrated healthcare system. Rheumatology International 35:11, pages 1799-1807.
Crossref
Crossref
Martijn A.H. Oude Voshaar, Thomas Bardin & Martinus A.F.J. van de Laar. (2015) The Human and Economic Burden of Difficult-to-Treat Gouty Arthritis. Joint Bone Spine 82, pages eS2-eS8.
Crossref
Crossref
Gemma E. Shields & Stephen M. Beard. (2015) A Systematic Review of the Economic and Humanistic Burden of Gout. PharmacoEconomics 33:10, pages 1029-1047.
Crossref
Crossref
Sharan K. Rai, Lindsay C. Burns, Mary A. De Vera, Aliya Haji, Dean Giustini & Hyon K. Choi. (2015) The economic burden of gout: A systematic review. Seminars in Arthritis and Rheumatism 45:1, pages 75-80.
Crossref
Crossref
Keith Rome & Mike Frecklington. 2015. Management of Chronic Conditions in the Foot and Lower Leg. Management of Chronic Conditions in the Foot and Lower Leg
52
69
.
Philip C. Robinson & Simon Horsburgh. (2014) Gout: Joints and beyond, epidemiology, clinical features, treatment and co-morbidities. Maturitas 78:4, pages 245-251.
Crossref
Crossref
Jasvinder A. Singh. (2014) Challenges Faced by Patients in Gout Treatment. JCR: Journal of Clinical Rheumatology 20:3, pages 172-174.
Crossref
Crossref
Laura BE Kienhorst. (2014) Gout: A clinical overview and its association with cardiovascular diseases. World Journal of Rheumatology 4:3, pages 62.
Crossref
Crossref
F. M. McQueen, A. Doyle, Q. Reeves, A. Gao, A. Tsai, G. D. Gamble, B. Curteis, M. Williams & N. Dalbeth. (2013) Bone erosions in patients with chronic gouty arthropathy are associated with tophi but not bone oedema or synovitis: new insights from a 3 T MRI study. Rheumatology 53:1, pages 95-103.
Crossref
Crossref
Fernando Perez-Ruiz & Ana Maria Herrero-BeitesFernando Perez-Ruiz & Ana Maria Herrero-Beites. 2014. Managing Gout in Primary Care. Managing Gout in Primary Care
1
12
.
Nicola Dalbeth, Fernando Perez-Ruiz & Naomi SchlesingerFernando Perez-RuizAne AltunaJoana Atxotegi. 2013. Gout. Gout
190
200
.
Jasvinder A. Singh. (2012) Racial and Gender Disparities Among Patients with Gout. Current Rheumatology Reports 15:2.
Crossref
Crossref
Puja P Khanna, George Nuki, Thomas Bardin, Anne-Kathrin Tausche, Anna Forsythe, Amir Goren, Jeffrey Vietri & Dinesh Khanna. (2012) Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey. Health and Quality of Life Outcomes 10:1.
Crossref
Crossref
William J. Taylor, Meaghan House, Anne Horne, Fiona M. McQueen & Nicola Dalbeth. (2012) The Work Instability Scale Predicts Absenteeism in People With Gout and Suggests a Higher Risk for Those in Manual Occupations. Journal of Clinical Rheumatology 18:8, pages 405-410.
Crossref
Crossref
John S. Sundy. (2012) The Rheumatology of Gout. Advances in Chronic Kidney Disease 19:6, pages 404-412.
Crossref
Crossref
Fernando Perez-Ruiz & Ana Maria Herrero-Beites. (2012) Evaluation and Treatment of Gout as a Chronic Disease. Advances in Therapy 29:11, pages 935-946.
Crossref
Crossref
Dinesh Khanna, Puja P. Khanna, John D. Fitzgerald, Manjit K. Singh, Sangmee Bae, Tuhina Neogi, Michael H. Pillinger, Joan Merill, Susan Lee, Shraddha Prakash, Marian Kaldas, Maneesh Gogia, Fernando Perez‐Ruiz, Will Taylor, Frédéric Lioté, Hyon Choi, Jasvinder A. Singh, Nicola Dalbeth, Sanford Kaplan, Vandana Niyyar, Danielle Jones, Steven A. Yarows, Blake Roessler, Gail Kerr, Charles King, Gerald Levy, Daniel E. Furst, N. Lawrence Edwards, Brian Mandell, H. Ralph Schumacher, Mark Robbins, Neil Wenger & Robert Terkeltaub. (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care & Research 64:10, pages 1447-1461.
Crossref
Crossref
Nicola Dalbeth & Karen Lindsay. (2011) The Patient’s Experience of Gout: New Insights to Optimize Management. Current Rheumatology Reports 14:2, pages 173-178.
Crossref
Crossref
Jennifer A Shannon & Sabrina W Cole. (2012) Pegloticase: A Novel Agent for Treatment-Refractory Gout. Annals of Pharmacotherapy 46:3, pages 368-376.
Crossref
Crossref
Peter M. ten Klooster, Harald E. Vonkeman & Mart A.F.J. van de Laar. (2012) Disability due to gouty arthritis. Current Opinion in Rheumatology 24:2, pages 139-144.
Crossref
Crossref
Fiona M. McQueen, Ashika Chhana & Nicola Dalbeth. (2012) Mechanisms of joint damage in gout: evidence from cellular and imaging studies. Nature Reviews Rheumatology 8:3, pages 173-181.
Crossref
Crossref
Keith Rome, Mike Frecklington, Peter McNair, Peter Gow & Nicola Dalbeth. (2012) Foot pain, impairment, and disability in patients with acute gout flares: A prospective observational study. Arthritis Care & Research 64:3, pages 384-388.
Crossref
Crossref
Rajendra K. Marwah. (2023) Comorbidities in Gouty Arthritis. Journal of Investigative Medicine 59:8, pages 1211-1220.
Crossref
Crossref
Howard S. Smith, Donna Bracken & Joshua M. Smith. (2011) Gout: Current Insights and Future Perspectives. The Journal of Pain 12:11, pages 1113-1129.
Crossref
Crossref